Skip to Main Content

In a bid to calm anxious patients, the Food and Drug Administration has extended the shelf life of a drug used to treat a rare form of glaucoma, which Pfizer (PFE) recently discontinued and may disappear altogether unless the company finds a suitable buyer.

The agency sent a notice to health care providers on Wednesday indicating that the shelf life for the medicine, known as phospholine iodide, would now run 12 months beyond the date stamped on its packaging, which would make “additional limited inventory of product available.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment